Matches in SemOpenAlex for { <https://semopenalex.org/work/W2891625480> ?p ?o ?g. }
- W2891625480 endingPage "432" @default.
- W2891625480 startingPage "425" @default.
- W2891625480 abstract "Three series of indolinone-based sulfonamides (3a-f, 6a-f and 9a-f) were in vitro evaluated as inhibitors of the tumor-associated carbonic anhydrase (CA, EC 4.2.1.1) isoforms hCA IX and XII, using a stopped-flow CO2 hydrase assay. All the investigated sulfonamides displayed single- or double-digit nanomolar inhibitory activities towards both hCA IX (KIs: 6.2-64.8 nM) and XII (KIs: 7.1-55.6 nM) isoforms. All sulfonamides (3a-f, 6a-f and 9a-f) were in vitro examined for their potential anticancer activity against colorectal cancer HCT-116 and breast cancer MCF-7 cell lines. Sulfonamide 9e was found to be the most potent counterpart against HCT-116 (IC50 = 3.67 ± 0.33 µM). Sulfonamide 9e displayed good selectivity profile for inhibition of the tumor-associated isoforms (CAs IX & XII) over the off-target cytosolic CAs I and II. 9e was screened for cell cycle disturbance and apoptosis induction in HCT-116 cells. It was found to persuade cell cycle arrest at G2-M stage as well as alter the Sub-G1 phase. Also, 9e induced the intrinsic apoptotic mitochondrial pathway in HCT-116 cells via down-regulation of the anti-apoptotic protein Bcl-2 level with concurrent boosting the pro-apoptotic Bax, caspase-9, caspase-3, cytochrome C and p53 levels." @default.
- W2891625480 created "2018-09-27" @default.
- W2891625480 creator A5018378636 @default.
- W2891625480 creator A5030732928 @default.
- W2891625480 creator A5051129755 @default.
- W2891625480 creator A5061206239 @default.
- W2891625480 creator A5067927306 @default.
- W2891625480 creator A5070924066 @default.
- W2891625480 creator A5079992878 @default.
- W2891625480 creator A5089443982 @default.
- W2891625480 date "2018-12-01" @default.
- W2891625480 modified "2023-10-14" @default.
- W2891625480 title "Tumor-associated carbonic anhydrase isoform IX and XII inhibitory properties of certain isatin-bearing sulfonamides endowed with in vitro antitumor activity towards colon cancer" @default.
- W2891625480 cites W1629423191 @default.
- W2891625480 cites W1644794975 @default.
- W2891625480 cites W1790711366 @default.
- W2891625480 cites W1972547175 @default.
- W2891625480 cites W1977258127 @default.
- W2891625480 cites W2002064506 @default.
- W2891625480 cites W2017688807 @default.
- W2891625480 cites W2020473971 @default.
- W2891625480 cites W2027692910 @default.
- W2891625480 cites W2047178318 @default.
- W2891625480 cites W2071264542 @default.
- W2891625480 cites W2080652879 @default.
- W2891625480 cites W2098685167 @default.
- W2891625480 cites W2108966286 @default.
- W2891625480 cites W2126326024 @default.
- W2891625480 cites W2139323228 @default.
- W2891625480 cites W2166819037 @default.
- W2891625480 cites W2172162633 @default.
- W2891625480 cites W2186736649 @default.
- W2891625480 cites W2273836722 @default.
- W2891625480 cites W2413943215 @default.
- W2891625480 cites W2464352601 @default.
- W2891625480 cites W2471456962 @default.
- W2891625480 cites W2480386350 @default.
- W2891625480 cites W2538009965 @default.
- W2891625480 cites W2577441808 @default.
- W2891625480 cites W2586746820 @default.
- W2891625480 cites W2591182350 @default.
- W2891625480 cites W2616790281 @default.
- W2891625480 cites W2736959870 @default.
- W2891625480 cites W2740059367 @default.
- W2891625480 cites W2744937568 @default.
- W2891625480 cites W2755599483 @default.
- W2891625480 cites W2781056088 @default.
- W2891625480 cites W2783760997 @default.
- W2891625480 cites W2788680860 @default.
- W2891625480 cites W2790386468 @default.
- W2891625480 cites W2792389705 @default.
- W2891625480 cites W2795680062 @default.
- W2891625480 cites W2797246868 @default.
- W2891625480 cites W2797930460 @default.
- W2891625480 cites W2806250050 @default.
- W2891625480 cites W2808522316 @default.
- W2891625480 cites W2811066730 @default.
- W2891625480 cites W2883701715 @default.
- W2891625480 cites W856882514 @default.
- W2891625480 doi "https://doi.org/10.1016/j.bioorg.2018.09.007" @default.
- W2891625480 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30219719" @default.
- W2891625480 hasPublicationYear "2018" @default.
- W2891625480 type Work @default.
- W2891625480 sameAs 2891625480 @default.
- W2891625480 citedByCount "50" @default.
- W2891625480 countsByYear W28916254802018 @default.
- W2891625480 countsByYear W28916254802019 @default.
- W2891625480 countsByYear W28916254802020 @default.
- W2891625480 countsByYear W28916254802021 @default.
- W2891625480 countsByYear W28916254802022 @default.
- W2891625480 countsByYear W28916254802023 @default.
- W2891625480 crossrefType "journal-article" @default.
- W2891625480 hasAuthorship W2891625480A5018378636 @default.
- W2891625480 hasAuthorship W2891625480A5030732928 @default.
- W2891625480 hasAuthorship W2891625480A5051129755 @default.
- W2891625480 hasAuthorship W2891625480A5061206239 @default.
- W2891625480 hasAuthorship W2891625480A5067927306 @default.
- W2891625480 hasAuthorship W2891625480A5070924066 @default.
- W2891625480 hasAuthorship W2891625480A5079992878 @default.
- W2891625480 hasAuthorship W2891625480A5089443982 @default.
- W2891625480 hasConcept C104317684 @default.
- W2891625480 hasConcept C153911025 @default.
- W2891625480 hasConcept C181199279 @default.
- W2891625480 hasConcept C185592680 @default.
- W2891625480 hasConcept C190283241 @default.
- W2891625480 hasConcept C202751555 @default.
- W2891625480 hasConcept C2775914622 @default.
- W2891625480 hasConcept C2780416268 @default.
- W2891625480 hasConcept C2781039511 @default.
- W2891625480 hasConcept C29537977 @default.
- W2891625480 hasConcept C502942594 @default.
- W2891625480 hasConcept C53345823 @default.
- W2891625480 hasConcept C55493867 @default.
- W2891625480 hasConcept C71240020 @default.
- W2891625480 hasConcept C86803240 @default.
- W2891625480 hasConceptScore W2891625480C104317684 @default.
- W2891625480 hasConceptScore W2891625480C153911025 @default.
- W2891625480 hasConceptScore W2891625480C181199279 @default.